A single clinic reviewed knee-pain records and contacted 16 of 17 patients by telephone. Twelve had received BPC-157 alone and four a combination with thymosin beta4.
What the researchers measured
Patients recalled changes in pain and how long improvement lasted. The study did not use specific standardized measures of function, stiffness, or quality of life.
How to read this evidence
Researchers observed people or measured naturally occurring peptide levels. Associations do not show that administering the peptide caused a benefit.
Results in context
Reported improvement was subjective and there was no untreated comparison group. The combination group cannot isolate BPC-157's contribution; the study did not demonstrate cartilage repair.
What this does not establish
Uncontrolled, subjective follow-up cannot establish efficacy. Combined treatment in some patients prevents attribution to BPC-157 alone.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.
Publication indexing
Journal Article
Indexed subjects
Activities of Daily Living · Humans · Injections, Intra-Articular · Osteoarthritis, Knee · Pain · Peptide Fragments · Proteins · Quality of Life · Retrospective Studies · Treatment Outcome
Source checked
October 4, 2026. Years follow journal issues; online-first dates may differ.